Kyverna reports first use of KYV-101 for multiple sclerosis treatment

cafead

Administrator
Staff member
  • cafead   Apr 02, 2024 at 11:42: AM
via Kyverna Therapeutics has published a report detailing the first-in-disease use of KYV-101 in patients with progressive multiple sclerosis (MS) under a named patient program in Germany.

article source